0001022079-22-000102.txt : 20220525
0001022079-22-000102.hdr.sgml : 20220525
20220525163118
ACCESSION NUMBER: 0001022079-22-000102
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220523
FILED AS OF DATE: 20220525
DATE AS OF CHANGE: 20220525
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: RUSCKOWSKI STEPHEN H
CENTRAL INDEX KEY: 0001142624
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-12215
FILM NUMBER: 22963336
MAIL ADDRESS:
STREET 1: C/O QUEST DIAGNOSTICS
STREET 2: 500 PLAZA DRIVE
CITY: SECAUCUS
STATE: NJ
ZIP: 07094
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: QUEST DIAGNOSTICS INC
CENTRAL INDEX KEY: 0001022079
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 161387862
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 500 PLAZA DRIVE
CITY: SECAUCUS
STATE: NJ
ZIP: 07094
BUSINESS PHONE: 9735202700
MAIL ADDRESS:
STREET 1: 500 PLAZA DRIVE
CITY: SECAUCUS
STATE: NJ
ZIP: 07094
FORMER COMPANY:
FORMER CONFORMED NAME: CORNING CLINICAL LABORATORIES INC
DATE OF NAME CHANGE: 19960903
4
1
wf-form4_165351065441914.xml
FORM 4
X0306
4
2022-05-23
0
0001022079
QUEST DIAGNOSTICS INC
DGX
0001142624
RUSCKOWSKI STEPHEN H
500 PLAZA DRIVE
SECAUCUS
NJ
07094
1
1
0
0
Chairman, CEO and President
Common Stock
2022-05-23
4
M
0
34898
103.57
A
369731
D
Common Stock
2022-05-23
4
S
0
33898
140.124
D
335833
D
Common Stock
2022-05-23
4
S
0
800
141.542
D
335033
D
Common Stock
2022-05-23
4
S
0
200
142.255
D
334833
D
Common Stock
2022-05-23
4
M
0
42568
86.63
A
377401
D
Common Stock
2022-05-23
4
S
0
41268
140.119
D
336133
D
Common Stock
2022-05-23
4
S
0
1000
141.509
D
335133
D
Common Stock
2022-05-23
4
S
0
300
142.24
D
334833
D
Common Stock
2022-05-24
4
M
0
126126
103.57
A
460959
D
Common Stock
2022-05-24
4
S
0
126126
140.12
D
334833
D
Common Stock
2022-05-24
4
M
0
156282
86.63
A
491115
D
Common Stock
2022-05-24
4
S
0
156282
140.122
D
334833
D
Non-Qualifed Stock Option (right to buy)
103.57
2022-05-23
4
M
0
34898
103.57
D
2028-02-19
Common Stock
34898.0
136163
D
Non-Qualifed Stock Option (right to buy)
86.63
2022-05-23
4
M
0
42568
86.63
D
2029-02-18
Common Stock
42568.0
171136
D
Non-Qualifed Stock Option (right to buy)
103.57
2022-05-24
4
M
0
126126
103.57
D
2028-02-19
Common Stock
126126.0
10037
D
Non-Qualifed Stock Option (right to buy)
86.63
2022-05-24
4
M
0
156282
86.63
D
2029-02-18
Common Stock
156282.0
14854
D
This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on April 22, 2022.
This transaction was executed in multiple trades at prices ranging from $140.00 to $140.95. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $141.11 to $141.99. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $142.22 to $142.29. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $140.00 to $140.94. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $141.11 to $141.93. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $142.21 to $142.29. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $140.00 to $140.68. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $140.00 to $140.80. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
The options vested in three annual installments beginning with the first on February 19, 2019, the second on February 19, 2020 and the final on February 19, 2021.
The options vested in three annual installments beginning with the first on February 18, 2020, the second on February 18, 2021 and the final on February 18, 2022.
/s/ William J. O'Shaughnessy, Jr., Attorney in Fact for Stephen H. Rusckowski
2022-05-25